Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Exploration of Targeted Anti-Tumor Therapy|March 24, 2025
Pancreatic cancer: failures and hopes-a review of new promising treatment approachesVittore Cereda, Mario Rosario D'Andrea
Exploration of Targeted Anti-Tumor Therapy|October 1, 2024
Combination of the PARPi and ARSi in advanced castration resistant prostate cancer: a review of the recent phase III trialsMartina Panebianco, Vittore Cereda, Mario Rosario D'Andrea
Critical Reviews in Oncology/Hematology|December 13, 2006
Gemcitabine in advanced biliary tract cancersLara Maria Pasetto, Mario Rosario D'Andrea, Cristina Falci, et al.
Critical Reviews in Oncology/Hematology|June 30, 2006
Oxaliplatin-related neurotoxicity: how and why?Lara Maria Pasetto, Mario Rosario D'Andrea, Elena Rossi, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
Antiangiogenic therapies in breast cancerRoberta Sarmiento, Mario Rosario D'Andrea, Francesca Cacciamani, et al.
Anticancer Research|June 3, 2006
Stable disease in advanced colorectal cancer: therapeutic implicationsLara Maria Pasetto, Mario Rosario D'Andrea, Antonio Jirillo, et al.
Critical Reviews in Oncology/Hematology|June 30, 2006
The development of platinum compounds and their possible combinationLara Maria Pasetto, Mario Rosario D'Andrea, Alba Ariela Brandes, et al.
Cancers|December 10, 2021
Propensity for Early Metastatic Spread in Breast Cancer: Role of Tumor Vascularization Features and Tumor Immune InfiltrateMario Rosario D'Andrea, Vittore Cereda, Luigi Coppola, et al.
Pharmaceutics|December 23, 2022
Association of HLA-G 3'UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal CancerLucia Scarabel, Jerry Polesel, Elena De Mattia, et al.
World Journal of Gastroenterology|September 22, 2017
Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directionsGuido Giordano, Massimo Pancione, Nunzio Olivieri, et al.
Pageof 3